Cheng et al. reported that TGF-β1 induced EMT in tumour cells through mammalian targeting of the Rapamycin/p70s6k/Pyruvate Kinase M2 (mTOR/p70s6k/PKM2) pathway [88,90]. This evidence concerns the gene MTOR and neoplasm.